+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free

Global Life Sciences BPO Market to be Boosted by Diverse Study Populations to US$286.3 bn by 2023

Posted on Apr 21, 2016

The global life sciences BPO market is expected to be valued at US$286.3 bn by the end of 2023. It was recorded at US$127.4 bn in 2014 and, according to a research report released by Transparency Market Research, is likely to expand at a CAGR of 8.90% during the forecast period of 2015 to 2023. The report, titled “Life Sciences BPO Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023,” highlights the key factors that can influence this market in the near future. 

Browse the full Life Sciences BPO Market (Contract Research Organizations (Drug Discovery, Pre-Clinical, Clinical Trials, Medical Writing, Pharmacovigilance, Clinical Data Management, Regulatory Services, Clinical Monitoring, Biostatistics, Protocol Development, and Site Management); Contract Manufacturing Organizations (Active Pharmaceutical Ingredient Manufacturing, Final Dosage Form Manufacturing, and Packaging); Contract Sales and Marketing Organizations; and Others (Payers and Providers))- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023 report at http://www.transparencymarketresearch.com/life-sciences-bpo-market.html

According to the report, the global life sciences BPO market is being driven by the growing access to a more diverse study population. Other drivers include the ones offered by the BPO market in general, such as increased work efficiency and lower costs of operation.

The report also sheds light on the steady increase of clinical trials due to globalization. Outsourcing is increasingly being used in clinical trials thanks to the ongoing globalization and the economic slowdown experienced by developed economies over the past decade. This fact is further amplified by the increasing regulatory pressure on clinical trials and studies within the U.S. – a key user of outsourcing strategies – and the relatively relaxed regulations in developing economies.

The global life sciences BPO market is also expanding at a faster pace due to the increased rate of outsourcing practices in the pharmaceutical industries, a factor attributed to the growing number of drug patent expirations and the increasing number of failed clinical trials.

Another major driver of the global life sciences BPO market is the increasing preference of biotech and pharma key players in core business segments. The market is, however, expected to be hindered by the breach of trade and other information lapses for pipeline drugs and the overall issues created by outsourcing, such as the lack of credibility of product quality and test results.

The global life sciences BPO market is segmented on the basis of services into pharmaceutical outsourcing and others. Within the segment of pharmaceutical outsourcing, the market was dominated by CROs. This sub-segment is growing due to the increasing costs of healthcare, which in turn, have increased the demand for generic drugs. The sub-segment of CMOs is expected to exhibit a significant growth rate owing to the high rate of internal research and development efforts as a part of client support services. API manufacturing forms the largest segment of the global CMO market, with its growth attributed to rapidly increasing outsourcing activities.

Key players in the global life sciences BPO market are Wipro Limited, Quintiles Transnational Corporation, PAREXEL International Corporation, Lonza Group, Infosys Limited, Covance, Inc., Cognizant Technology Solutions, and Accenture plc.

Key segments of the Global Life Sciences BPO Market

  • Global Life Sciences BPO Market, by Services
    • Pharmaceutical outsourcing
      • Contract Research Organizations
        • Drug Discovery
        • Preclinical Studies
        • Clinical Trials
        • Medical Writing
        • Pharmacovigilance
        • Clinical Data Management
        • Regulatory Services
        • Clinical Monitoring
        • Biostatistics
        • Protocol Development
        • Site Management
      • Contract Manufacturing Organizations
        • Active Pharmaceutical Ingredients
        • Finished Dose Form Manufacturing
        • Packaging
      • Contract Sales and Marketing Organizations
    • Others (Payers and Providers)
       
  • Global Life Sciences BPO Market, by Geography
    • North America
      • United States
      • Canada
    • Europe
      • United Kingdom
      • Germany
      • Rest of the Europe
    • Asia Pacific
      • China
      • India
    • Rest of the World
      • Latin America
      • Middle East and Africa

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact                                 

Mr.Sudip S
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

Back To Top